Erik Serrao discusses the data from a recently-completed field validation trial in southeastern Uganda. In this collaboration with the Sickle Cell Association of Uganda, led by Ruth Nankanja, HemoTypeSC correctly identified the hemoglobin type of 1,000 out of 1,000 children screened.
Dr. Alayo Sopekan, National Desk Officer, Ministry of Health, said: “Nigeria has the highest burden of Sickle Cell Disease (SCD) in the world ahead of Democratic Republic of Congo and India.” He called for early diagnosis and treatment of the disease.
Video: Nigerian officials reveal how the country loses over 150,000 newborns to sickle cell disease every year. OakTV presents a report on the accuracy of HemoTypeSC™, a 10 minute investigational test kit.
Video: Professor Obiageli Nnodu, sickle cell disease expert from the University of Abuja, describes the current status of sickle cell disease in Nigeria and the results from early testing with HemoTypeSC™.
The HemoTypeSC™ test has received the CE Mark, which is a certification that indicates conformity with health and safety standards set by the European Economic Area (EEA). HemoTypeSC™ is thus commercially available as an IVD in the EEA, and the CE Mark will facilitate availability of the test to all African and Indian populations that need it most.